SIDP Journal Club Series: A Randomized Trial of Hydroxychloroquine for COVID-19: Does the Search Continue?

A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) 

 
 View more SIDPEC Activities
 

Activity Description

The purpose of this recurring activity is to review a recent infectious disease journal article and critically evaluate study rationale and design, results, strengths/limitations of the research, and applicability of findings to clinical practice. This activity will be repeated on a quarterly basis with a focus on a different journal article and study design each time.

An open-access journal article will be selected for the activity, and a step-by-step commentary created by the faculty will be made accessible to participants. Participants are invited to read the selected article, review the downloadable commentary prepared by the faculty, and successfully complete an online assessment to claim continuing education and/or BCIDP recertification credit. A Journal Club Twitter chat (using hashtag #SIDP_JC) will be scheduled approximately 2 weeks after activity launch to facilitate additional discussion surrounding the selected article, though this is not a requirement to claim continuing education and/or BCIDP recertification credit. Participants may claim credit at any time after successfully completing the assessment.

Learning Objectives

The target audience for this activity includes pharmacists and board-certified infectious diseases pharmacists (BCIDPs) seeking to update their knowledge and skills related to contemporary infectious diseases literature review. At the completion of this activity, the participant will be able to:

  • Describe study rationale and design as it relates to a recent infectious diseases journal article.
  • Summarize the statistical methods used by the investigators, including a rationale for the methods selected.
  • Assess study results to form a conclusion about primary and secondary outcomes.
  • Determine the clinical applicability of study findings while considering strengths and limitations of the research.

Faculty

Vasilios Athans, PharmD, BCPS, BCIDP
Clinical Pharmacy Specialist, Infectious Diseases
Hospital of the University of Pennsylvania

CE Accreditation

Release Date: May 4, 2020
Expiration Date: May 4, 2023

Pharmacists

This activity is jointly provided by ProCE, Inc. and the Society of Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-222-H01-P has been assigned to this home study, knowledge-based activity. This activity is approved for 1.5 contact hour (0.15 CEU) in states that recognize ACPE providers. Completion of the evaluation and the post-test with a score of 70% or higher are required to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.

BCIDP

The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certified infectious diseases pharmacist (BCIDP) credit. A BCIDP statement of credit will be issued online upon successful completion of a post-test and online evaluation. The post-test must be successfully completed in only one attempt. No partial credit will be given. BCIDP accreditation begins 05/04/2020 for this activity and is available for one year from this date.

Recertification Criteria for Infectious Diseases Pharmacy: BCIDP recertifying via continuing education are required to earn 100 hours of continuing education credit provided by the joint program offered by the American College of Clinical Pharmacy (ACCP) and the American Society of Health-System Pharmacists (ASHP) and/or the Society of Infectious Diseases Pharmacists (SIDP). Infectious Diseases Pharmacy Specialty Recertification Courses offered by any of the approved providers may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle. Candidates should note that there are expiration dates associated with earning BPS recertification credit. BPS will only award recertification credit for modules based on the completion and submission date of the post-test assessment. For example, a module completed and submitted on October 20 of a particular year will only be credited for that year, even if the due date of the post-test is in January of the following year. View all recertification criteria on the BPS website at https://www.bpsweb.org/recertification/recertification-by-continuing-education

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Vasilios Athans has served as a speaker for Merck & Co.

Funding

This activity is provided by ProCE, Inc. and SIDP.

    

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.